Filing Details

Accession Number:
0001593968-23-001469
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-29 14:29:03
Reporting Period:
2023-11-28
Accepted Time:
2023-11-29 14:29:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1673772 Rapt Therapeutics Inc. RAPT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1400901 William Ho C/O Rapt Therapeutics, Inc.,
561 Eccles Avenue
South San Francisco CA 94080
Chief Medical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-11-28 1,500 $13.72 17,520 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person on October 17, 2022.
  2. Includes 231 shares acquired by Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on October 31, 2023.